Inhibikase Therapeutics: Q2 Earnings Insights By: Benzinga via Benzinga August 12, 2022 at 16:58 PM EDT Inhibikase Therapeutics (NASDAQ:IKT) reported its Q2 earnings results on Friday, August 12, 2022 at 04:00 PM. Here's ... Read More >> Related Stocks: Inhibikase Therapeutics Inc